awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q41862291-21745167-F3F4-4FBD-B3DB-8498561F4FC9
Q41862291-21745167-F3F4-4FBD-B3DB-8498561F4FC9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41862291-21745167-F3F4-4FBD-B3DB-8498561F4FC9
Newer antithrombotic drugs
P2860
Q41862291-21745167-F3F4-4FBD-B3DB-8498561F4FC9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41862291-21745167-F3F4-4FBD-B3DB-8498561F4FC9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
225fec271569a780470219b4ac845d9ea194863b
P2860
Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y(12)-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percuta